The USC Roski Eye Institute has always been on the forefront of the latest advancements in glaucoma treatment. Our exceptional team of ophthalmologists have helped pioneer many of the life-changing treatment options now available for one of the most common causes of preventable blindness in the U.S. and worldwide.Interim Dean of the Keck School of Medicine of USC, Professor and Chair of the Department of Ophthalmology, Director of the USC Roski Eye Institute, and glaucoma expert, Rohit Varma, MD, MPH, has not only led the way in improving glaucoma treatments, but he has also co-authored and co-edited several textbooks on the subject, including the recently released Advanced Glaucoma Surgery, to help provide a comprehensive source of cutting-edge information regarding advanced glaucoma surgical techniques for other ophthalmologists, researchers, and students.
The Glaucoma Service at the USC Roski Eye Institute offers comprehensive care and treatment for the full range of glaucoma conditions. The following are some of the most state-of-the-art advancements available for preventing, diagnosing, and treating the group of diseases that make up glaucoma.
Glaucoma Drainage Devices
The USC Roski Eye Institute researchers have developed an effective alternative to trabeculectomies and tube shunts that have traditionally been used to relieve intraocular pressure (IOP) issues that damage the optic nerve. The stent is no wider than a human hair and consists of collagen-derived gelatin. The stent can be safely injected into the eye to allow the eye’s anterior chamber to continue circulating and draining fluid in the inner eye. The glaucoma stents, such as iStent, can be implanted within a matter of minutes.
Intraocular Pressure Sensors
Researchers at the USC Roski Eye Institute are also currently working on novel intraocular pressure sensors that would be implanted in the eye to accurately and continuously measure IOP on a daily basis. While it is possible to gauge intraocular pressure during an eye exam, the internal pressure of the eye changes regularly throughout a single day. If the pressure raises too high, even temporarily, the optic nerve can be damaged, leading to vision loss. An intraocular pressure sensor would track an individual’s IOP and transmit the information to a wireless receiver for an ophthalmologist to analyze and monitor for signs of glaucoma.
Drug Delivery Systems
Glaucoma is a chronic eye disease that can be managed or slowed down with certain medications depending on the patient. However, administering the appropriate medication on a consistent basis, especially as eye drops, can be difficult for many patients. The USC Roski Eye Institute researchers have developed a minuscule implantable pump that can deliver medication at regular intervals directly into the eye. The implant is refillable and can be programmed and recharged with the convenience of a wireless device.
Advancing Eye Care at USC Roski Eye Institute
The board-certified ophthalmologists at the USC Roski Eye Institute are experienced at diagnosing and treating glaucoma as well as conducting clinical trials to help advance eye care treatments to prevent vision loss. Please do not hesitate to get in touch with us by completing our online contact form or simply calling (323) 745-2223. We are located in Los Angeles, Arcadia, Beverly Hills, and Pasadena.
For more information about the USC Roski Eye Institute or to support the Institute by making a tax-deductible gift, please contact Rebecca Melville, senior director of development, at 323.442.5396 or via email at Rebecca.Melville@med.usc.edu.